Amphion Innovations (AMP)

 

AMP Share PerformanceMore

52 week high4.7000 21/04/17
52 week low1.2500 02/08/17
52 week change -1.5000 (-46.15%)
4 week volume2,181,379 29/08/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Amphion reduces stake in Motif Bio

Amphion Innovations has soled 1,700,000 shares in partner company, Motif Bio, in partial repayment of the loan facility or...

Holding(s) in Company

RNS Number: 2342P Motif Bio PLC 30 August 2017 30 August 2017 Motif Bio plc ("Motif" or the "Company") Motif Bio plc (AIM: MTFB), the clinical stage biopharmaceutical company specialising in developing novel antibiotics, announces that it was informed on 29 August 2017 by Amphion Innovations plc ("Amphion") that 1,700,000 ordinary shares in the Compa...

Sale of partner company shares

RNS Number: 2325P Amphion Innovations PLC 30 August 2017 Amphion Innovations plc ("Amphion" or "the Company") 30 August 2017 Sale of Partner Company Shares London and New York, Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, today announces that 1,700,000 shares in Partner Company, Motif ...

AGM Statement

RNS Number: 8103M Amphion Innovations PLC 01 August 2017 Amphion Innovations plc ("Amphion" or "the Company") 1 August 2017 Results of AGM London and New York, 1 August 2017 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, today announces that all resolutions were passed at the Annual Gene...

FTSE falls on mixed bag led by utilities, oil majors

London shares opened firmly lower on Wednesday with blue chips retreating on weakness in a palette of sectors, with utili...

Final Results

RNS Number: 3529J Amphion Innovations PLC 28 June 2017 Amphion Innovations plc ("Amphion" or the "Company") Final results London and New York, 28 June 2017 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces its audited results for the year ended 31 December 2016. Financial Results: Net A...

Amphion partner company agrees merger

Amphion Innovations partner company, m2m Acquisition Inc and North Carolina-based Polarean Inc have signed a defin...

Partner Company m2m Imaging merger update

RNS Number: 6262G Amphion Innovations PLC 31 May 2017 Amphion Innovations plc ("Amphion" or the "Company") 31 May 2017 Partner Company m2m Imaging merger update Amphion Partner Company, m2m Acquisition Inc, and Polarean Inc. to create Polarean Imaging Limited in a cash and share merger Polarean Imaging Limited announces the closing o...

Equity Research (AMP)

Amphion Innovations Plc
26/01/2017
Accessing Fast Growing Early Stage Tech Stocks Not everyone is able to access fast growing technology stocks directly. This could be because of; suitability issues; or lack of portfolio scale to...

Latest discussion posts More

  • Re: Expensive drawdown facility

    What to do? Sell or avoid? Have been watching this, but any upside to Motif will simply mean AMP selling stake to pay the debt/bills? Will any Motif windfall be squandered? ...
    15-Jul-2016
    bobsson
  • Re: Expensive drawdown facility

    Agree wholeheartedly! Conflicted company officers are electing, against their fiduciary duty, to unecessarily bleed our company dry when cheaper funding could clearly be ...
    13-Jul-2016
    nodebt
  • Expensive drawdown facility

    This facility seems very expensive $750,000 borrowed today and $881,000 having to be repaid in less than 4 months time and some of it being used to pay back a previous ...
    13-Jul-2016
    northumbrian-piper

Users' HoldingsMore

Users who hold Amphion Innovations also hold..
ASHLEY HOUSE20%
LLOYDS GRP.20%
MOTIF BIO20%
BP16%
PRIMORUS INV.16%

Codes & Symbols

ISINGB00B0DJNP99
SymbolsAMP, LSE:AMP, AMP.L, AMP:LN, LON:AMP, XLON:AMP